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Naive hypomethylated embryonic pluripotent stem cells (ESCs) are developmentally closest to the preimplanta-
tion epiblast of blastocysts, with the potential to contribute to all embryonic tissues and the germline, excepting the 
extra-embryonic tissues in chimeric embryos. By contrast, epiblast stem cells (EpiSCs) resembling postimplantation 
epiblast are relatively more methylated and show a limited potential for chimerism. Here, for the first time, we re-
veal advanced pluripotent stem cells (ASCs), which are developmentally beyond the pluripotent cells in the inner 
cell mass but with higher potency than EpiSCs. Accordingly, a single ASC contributes very efficiently to the fetus, 
germline, yolk sac and the placental labyrinth in chimeras. Since they are developmentally more advanced, ASCs do 
not contribute to the trophoblast. ASCs were derived from blastocysts in two steps in a chemically defined medium 
supplemented with Activin A and basic fibroblast growth factor, followed by culturing in ABCL medium containing 
ActA, BMP4, CHIR99021 and leukemia inhibitory factor. Notably, ASCs exhibit a distinct transcriptome with the 
expression of both naive pluripotency genes, as well as mesodermal somatic genes; Eomes, Eras, Tdgf1, Evx1, hand1, 
Wnt5a and distinct repetitive elements. Conversion of established ESCs to ASCs is also achievable. Importantly, 
ASCs exhibit a stable hypermethylated epigenome and mostly intact imprints as compared to the hypomethylated 
inner cell mass of blastocysts and naive ESCs. Properties of ASCs suggest that they represent cells at an intermediate 
cellular state between the naive and primed states of pluripotency.
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Introduction
Development of zygotes to blastocysts is accompanied 
by a sequential change from totipotency to pluripotency, 
with differentiation of the outer trophectoderm cells and 
the pluripotent cells in the inner cell mass (ICM). The 
ICM gives rise to all the somatic tissues, as well as germ 
cells. Pluripotent embryonic stem cells (ESCs) isolated 
from the ICM are in vitro counterparts [1-3], which when 
introduced into the blastocysts can differentiate into all 
fetal tissues and germ cells, albeit making an insignifi-
cant contribution to the extraembryonic tissues [4]. 
Following blastocyst implantation, epiblast cells in 
postimplantation embryos retain some characteristics of 
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pluripotency while becoming progressively more hyper-
methylated before the initiation of somatic cell fates [5, 6]. 
Epiblast stem cells (EpiSCs) from postimplantation epi-
blast cells are hypermethylated but retain some features 
of pluripotency [7, 8], where female EpiSCs have an 
inactive X chromosome [9]. A variety of self-renewing 
pluripotent stem cells have been reported [10-14], with 
variable potencies, epigenetic states and transcriptional 
regulators. These cells have been generated in vitro using 
empirical combinations of cytokines, fetal calf serum and 
hormones, including mouse embryonic fibroblasts (MEF) 
as feeders.
Here, ASCs showed unique properties with the ex-
pression of naive pluripotency and some mesodermal 
somatic genes in chemically defined medium without 
serum. Importantly, these cells were also hypermethyl-
ated relative to naive ESCs. Altogether, ASCs represent 
an early postimplantation epiblast-like state of devel-
opment. However, when injected into host blastocysts, 
single ASC contributed to embryonic tissues, germline, 
yolk sac and placental labyrinth that originate from the 
postimplantation epiblast, but did not contribute to the 
trophoblast. ASCs exhibit unique features and provide a 
new model for investigations on the epigenetic and tran-
scriptional states that regulate cell potency.
Results
Derivation and characterization of AFSCs
First, we attempted to derive stem cells from blasto-
cysts in a chemically defined medium with N2B27 in 
the presence of ActA and basic fibroblast growth factor 
(bFGF) (but excluding KSR and feeder cells). Most of 
the E3.5 blastocysts attached within 5-6 days, forming 
ICM outgrowth, of which ~20% resulted in stable lines 
from diverse genetic backgrounds; we designated these 
as ActA/bFGF stem cells (AFSCs) (Figure 1A and 1B). 
The rate of AFSC derivation was similar to that reported 
previously for naive ESCs in 2i/LIF [15].
Immunofluorescence (IF) and RT-qPCR analysis of 
AFSCs revealed expression of OCT4, SOX2, NANOG, 
E-cadherin; we also detected H3K27me3 which is a 
distinctive mark of an inactive X chromosome (Figure 
1C; Supplementary information, Figure S1A). AFSCs 
share similarities with EpiSCs [7, 8], where expression 
of some genes of the ICM and ESCs were significantly 
reduced, including Prdm14, Tbx3, Tcl1, Klf2, Esrrb, Klf4 
and Rex1. By contrast, we observed higher expression of 
early germ layer genes Eomes, Lefty1 and brachyury (T) 
(Figure 1C), together with the strong expression of Sox17 
and Blimp1. AFSCs also uniquely displayed expression 
of Gata6 and Gata4, which are a part of the primitive en-
doderm transcriptome (Figure 1C). Overall, AFSCs were 
clearly at a stage beyond the pluripotent state of epiblast 
cells in blastocysts but as teratomas, they were still able 
to differentiate into cells of all the three germ layers 
(Supplementary information, Figure S1B). 
Next, following the injection of 15-20 AFSCs with 
Rosa26-LacZ reporter into E3.5 blastocysts, we detected 
their contribution (~11%-14%) in chimeric embryos at 
E6.5-E8.5 (Supplementary information, Figure S1C , S1D 
and Table S1A), which is unlike EpiSCs [7, 8]. More 
strikingly, their high contribution was found in the poste-
rior primitive streak and the extra-embryonic mesoderm 
surrounding the epiblast in E6.5-E7.5 chimeric embryos 
(Supplementary information, Figure S1C and S1D). The 
latter develops into the yolk sac and contributes in part to 
the placenta. Thus, AFSCs are distinct and, unlike plurip-
otent EpiSCs.
Derivation and characterization of ASCs
Next, we explored the impact of Wnt and BMP4 sig-
naling on AFSCs, which can substitute for serum in ESC 
cultures [16, 17], and induce differentiation of EpiSCs 
[18, 19]. Using CHIR99021 (CH) for simulating canon-
ical Wnt signaling [20], we started with two established 
AFSCs cell lines with GOF-GFP or Stella-GFP reporters. 
AFSCs were dissociated and cultured in N2B27 medi-
um with ActA, BMP4, CH and LIF (henceforth called 
ABCL medium) (Figure 1D). After 10 days, we detected 
GOF-GFP-positive clones, which were able to self-renew 
for more than 30 passages. We designated these cells as 
advanced pluripotent stem cells (ASCs) and compared 
them with EpiSCs (Supplementary information, Table 
S1B).
To determine the key features of ASCs relative to 
ESCs, we examined expression by IF for cMYC, KLF4, 
E-cadherin, ESRRB and PRDM14. Excluding the higher 
expression of cMYC in ASCs than in ESCs, expression 
of other genes was equivalent to that in ESCs (Figure 2A). 
Notably, high expression of cMYC in ESCs promotes rap-
id transition through the G1 phase of the cell cycle, sup-
presses differentiation and controls pluripotency [21]. 
Next, we assessed the differentiation potential of 
ASCs with GOF-GFP reporter in chimeric embryos by 
injecting 15 cells into individual blastocysts. We found 
that ASC contributed to the embryo proper and germline 
of E12.5 embryo, as well as to the full-term pups (Fig-
ure 2B and 2C; Supplementary information, Table S1C 
and S1D). Importantly, ASCs contributed to the placenta 
in chimeric conceptuses (Supplementary information, 
Figure S2A), which was also the case with the other 
ASC line harboring Stella-GFP reporter (Supplementa-
ry information, Figure S2B). Furthermore, using ASCs 
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Figure 1 Derivation of AFSCs and ASCs. (A) Schematic overview of AFSC derivation. Note AP-positive cells (arrow indicat-
ed) in AFSCs. Scale bars, 100 µm. (B) Derivation rate of AFSCs with diverse genetic backgrounds. (C) Quantitative RT-PCR 
of key genes in ESCs, EpiLCs, AFSCs and EpiSCs, all derived from 129/sv females mated with GOF-GFP males of mixed 
background. Note the expression of endoderm and mesoderm genes in AFSCs (at the bottom). (D) Reprogramming AFSC to 
ASCs. Scale bar, 100 µm.
with GOF-GFP and a constitutive tdTomato reporter, 
we detected these cells in the placental labyrinth (Figure 
2D; Supplementary information, Figure S2C), yolk sac 
(Figure 2E and 2F), embryo proper and the germline at 
E10.5-E13.5 (Supplementary information, Figure S2D, 
S2E and Table S1E). Notably, ASCs contributed to more 
than 50% of the extra-embryonic mesoderm of yolk sac, 
but there was no detectable contribution to the extra-em-
bryonic endoderm of yolk sac (Figure 2E and 2F). This 
result indicates that ASCs are in a stable state between 
pluripotency and the onset of differentiation, with a po-
tential to contribute to embryos, yolk sac and placental 
labyrinth. 
For a further stringent test of the potency of ASCs, we 
introduced them into tetraploid host blastocysts, where 
the donor cells contribute predominantly if not exclu-
sively to the embryo [22]. Using 15 donor ASCs, we ob-
tained live pups with normal fertility at a higher rate than 
reported previously [23, 24] (Figure 2G and 2H; Sup-
plementary information, Table S1F). The derivation effi-
ciency of clonal lines from single ASC was equivalent to 
that of naive ESCs and much higher than that of EpiSCs 
or AFSCs (Figure 2I). Thus WNT and BMP4 signaling 
pathways increase the potency of AFSCs in the course of 
ASC derivation, and this potency exceeds that shown by 
EpiSCs in vivo.
Finally, we tested the potency of ASCs more stringent-
ly by introducing single ASCs into 8-cell stage embryos, 
which were cultured overnight and then transferred to re-
cipient females. We found that 24%-36% of the embryos 
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Figure 2 Characteristics of ASCs. (A) IF staining assays in ESCs and ASCs, including those detect the expression of KLF4, 
E-CADHERIN, ESSRB and PRDM14 in ASCs. Scale bars, 10 µm. (B) Germline transmission of ASCs in E12.5 chimeras 
shown by GOF-GFP-positive cells (arrow). Scale bars, 100 µm. (C) Chimeric pups (arrows) generated by injecting ASCs in 
ICR host blastocysts. (D) A schematic depiction of placenta tissue indicates the contribution of ASCs (tdTomato) to labyrinth 
of placenta in E10.5 chimeras (white arrows). Scale bars, 1 mm. (E, F) Schematic depiction of the yolk sac, and the contri-
bution of ASCs (tdTomato) to the extraembryonic mesoderm (red) in E10.5 chimeras. Scale bars, 100 µm. (G) Pups (arrows) 
generated entirely from ASCs (between 129/sv females and GOF-GFP males) in tetraploid ICR host blastocysts. (H) The F1 
pups generated by ASCs-tetraploid male (arrows) mated with ICR female. (I) The efficiency of clonal line derived from single 
ASCs. (J) Chimeras (E6.5-E10.5) generated with single ASC. White arrows indicate embryonic body; yellow arrows mark yolk 
sac; and red arrows point placenta. Scale bars for E6.5-7.5, 200 µm; scale bars for E8.5-10.5, 2 mm. ExM, extraembryonic 
mesoderm; la, labyrinth; st, spongetrophectoderm; tg, trophectoderm giant cell; VEnd, visceral endoderm.
at E6.5-E7.5 and 31%-50% of the embryos at E8.5-E10.5 
contained derivatives of ASCs with tdTomato reporter 
(Figure 2J; Supplementary information, Figure S2F and 
Table S2A). We also observed germline transmission and 
full-term chimeras from single ASCs (Supplementary 
information, Table S2B and S2C). Additional analysis 
of 18 conceptuses at E8.5-E10.5 resulting from single 
donor ASCs showed 14 chimeras (78%) with contribu-
tions to the embryo, yolk sac and the placenta (Figure 
2J; Supplementary information, Figure S2F and Table 
S2A). In contrast, single naive donor ESCs cultured in 
2i/LIF resulted in just 2/20 chimeras, with a contribution 
to the embryo, and no contribution to the extraembryonic 
tissues. When the number of donor cells was increased 
to 15, we obtained 18 chimeras, in which donor cell 
contributed predominantly to the fetus. However, in only 
one of these chimeras, ESC cells contributed to the fetus, 
yolk sac and the placenta (Supplementary information, 
Table S2D). Altogether, ASCs exhibit a unique pluripo-
tent state, with high clonogenicity and potency, and a sin-
gle ASC contributed to the embryo, placental labyrinth 
and the germline. 
To test for the potential for the conversion of ESCs 
(2i/LIF) to ASCs, we cultured two ESC cell lines (SQ3.3 
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and E14). Both cell lines demonstrated normal growth 
and were passaged over 20 times in ABCL medium; and 
the resulting cells was designated as ESC-ASCs. We test-
ed the in vivo developmental potential of ESC-ASCs in 
chimeras using single or multiple ESC-ASCs. We found 
that both single and multiple ESC-ASCs contributed to 
the embryo, yolk sac and placenta labyrinth (Supplemen-
tary information, Figure S2G; Supplementary informa-
tion, Table S2E). Thus ESCs can be converted to ASCs 
by culturing in ABCL, exhibiting increased potency and 
characteristics resembling ASCs.
Molecular features of ASCs
To investigate the molecular features of ASCs, we pro-
filed their transcriptome by RNA sequencing (RNA-seq), 
and compared it with naive ESCs (cultured in 2i/LIF), 
EpiSCs and EpiLCs (epiblast-like cells) (Supplementary 
information, Table S3A). Unsupervised hierarchical clus-
tering (UHC) showed that ASCs and naive ESCs cluster 
together, whereas AFSCs are close to EpiSCs (Figure 
3A; Supplementary information, Figure S3A). Moreover, 
the t-distributed stochastic neighbor embedding (t-SNE) 
analysis indicated a trajectory representing naive to 
primed cell states from ESCs and ASCs toward EpiLCs, 
and to more advanced AFSCs and EpiSCs (Figure 3B). 
We examined the similarities and differences among 
the five cell types by analyzing a total of 2 588 differen-
tially expressed genes. These genes were segregated into 
five distinct classes by UHC (Figure 3C; Supplementary 
information, Table S3B and S3C). All the five pluripo-
tent cell types expressed core pluripotency factors Oct4, 
Sox2 and Nanog (Figure 3D), but the expression of naive 
pluripotency genes (e.g., Esrrb, Tfcp2l1, Klf4, Tbx3 and 
Prdm14) was detected exclusively in ASCs and ESCs 
(cluster 2, Figure 3C and 3D), which was confirmed by 
IF analysis (Figure 2A). On the other hand, AFSCs and 
EpiSCs showed enrichment for developmental genes, 
including Otx2, Zic2, T, Eomes and Foxa2 (cluster 4, 
Figure 3D). 
Notably, we found that 421 genes were exclusively ex-
pressed in ASCs (cluster 3, Figure 3C), including genes 
that encode preferentially expressed antigen of mela-
noma (PRAME) family and translation initiation factor 
1A (see below). Principal component analysis (PCA) of 
transposable element expression also showed a similar 
trajectory from naive to primed cell states as seen by an-
alyzing the overall gene expression profiles (Supplemen-
tary information, Figure S3B). Notably, both ESCs and 
ASCs showed high expression of RLTR45, RMER16 and 
LTRIS2 (Supplementary information, Figure S3C), which 
might distinguish them from EpiSCs.
Next, we tested if ASCs correspond to cells at a par-
ticular embryonic developmental stage by comparing 
the ASC transcriptome with that of E2.5-E5.5 embryos 
[25] (Supplementary information, Table S3D). We per-
formed t-SNE and UHC analyses with 1 685 genes that 
are dynamically expressed between E2.5 and E5.5 stages 
[25]. Naive ESCs and ASCs were clustered with E4.5 
preimplantation epiblast, with ASCs being slightly more 
advanced than ESCs (Figure 3E; Supplementary infor-
mation, Figure S3D). EpiLCs were clustered with E5.5 
postimplantation epiblast, while AFSCs and EpiSCs had 
progressed to more advanced stages [26-28] (Figure 3E; 
Supplementary information, Figure S3D). Consistently, 
the comparison between ASCs and naive ESCs suggest-
ed the expression of the core genes (e.g., Oct4, Nanog 
and Sox2) and naive pluripotency genes (e.g., Esrrb, 
Klf4 and Tfcp2l1) in both of them. However, ASCs also 
showed upregulation of some primitive streak and me-
soderm genes, including Eomes, Eras, Evx1, Hand1 and 
Hoxa10 (Figure 3F; Supplementary information, Figure 
S3E). Furthermore, ASCs exhibited high gene expression 
level and protein abundance for cell-adhesion molecule 
E-cadherin (Cdh1) and c-Myc (Figures 2A and 3F). Al-
though T and Cdx1 IF also showed heterogeneity among 
ASCs, the consistent contribution of single ASCs to chi-
meras suggests the presence of a dynamic equilibrium 
(Supplementary information, Figure S3F). We also not-
ed a slightly higher expression of Hoxa genes in ASCs 
compared to ESCs, including Hoxa1, Hoxa5, Hoxa9, 
Hoxa10, Hoxa11, Hoxa11os, and Hoxa13 (Supplementary 
information, Figure S3G). In this context, the lncRNA 
Haunt/Halr1 that locates ~40 kb upstream of the Hoxa 
cluster [29-31] also displayed higher expression in ASCs 
than ESCs (Supplementary information, Figure S3G).
Further examination of ASCs (cluster 3, Figure 3C; 
Supplementary information, Table S3B) revealed ex-
pression of so-called 2C genes: Zscan4b, Zscan4d and 
Zscan4e (Figure 3D; Supplementary information, Figure 
S4A and Table S3E), and MERVL transcripts (Supple-
mentary information, Figure S3C) [12, 32-34]. Howev-
er, IF analysis showed that only 8% of the ASCs were 
MERVL-Gag positive/OCT4 negative, but such cells 
were rarer in 2i/LIF ESCs (Supplementary information, 
Figure S4A and S4B). Nonetheless, this does not account 
for the potency of ASC, since ESC-ASCs showed similar 
characteristics in the absence of 2C-like gene expression 
(Supplementary information, Figures S2G, S4C and 
S4D).
To this end, we injected a single ASC cell with td-
Tomato and GOF-GFP into an 8-cell stage embryo and 
examined its chimeric contribution after 48 h of in vitro 
culturing. Consistently, ASC contributed only to the 
ICM, and not to the trophoblast in blastocysts (0/42 re-
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covered blastocysts) (Supplementary information, Figure 
S4E). 
ASCs exhibit a hypermethylated stable methylome
Naive ESC pluripotent state displays global DNA hy-
pomethylation, where both X chromosomes are active 
in female cells [15, 35, 36]. Considering the enhanced 
potency of ASCs described above, we examined the 
epigenome of ASCs. Our initial IF observations showed 
bright H3K27me3 foci in female AFSCs, but not in 
female ASCs, suggesting reactivation of the X-chromo-
some in ASCs (Supplementary information, Figure S5A).
We further performed DNA methylation analysis of 
female ASCs, ESCs and EpiSCs by whole-genome bi-
sulfite sequencing (BS-seq) (Supplementary information, 
Table S3F). Although naive ESCs (2i/LIF) were globally 
hypomethylated (median CpG methylation of ~20%), 
ASCs showed a hypermethylated genome (median 
~70%) (Figure 4A). Indeed, UHC analysis revealed that 
the methylome of ASCs was more similar to the hyper-
methylated epigenome of EpiSCs (median 90%) (Figure 
4B; Supplementary information, Figure S5B). Most ge-
nomic regions, including promoters, enhancers, exons, 
introns and intergenic regions, were highly methylated in 
ASCs (Supplementary information, Figure S5C). In line 
with a previous report [35], all genomic imprints were 
erased in female 2i/LIF ESCs, whereas most imprints 
were retained in both ASCs and EpiSCs (Figure 4C). 
The retention of imprints, which are essential for devel-
opment, would make ASCs more robust in culture, and 
during subsequent differentiation.
To characterize the methylome further, we calculated 
hypermethylated regions (HyperMRs) in ESCs and hy-
pomethylated regions (HypoMRs) in ASCs and EpiSCs 
using a hidden Markov model [37]. We found very few 
HyperMRs in 2i/LIF ESCs (1 910); and most of these 
regions also showed high methylation levels in ASCs 
and EpiSCs (Figure 4D). We then focused on comparing 
the methylomes of ASCs and EpiSCs. Among the 51 126 
HypoMRs in ASCs, 27 217 (53%) were not present in 
EpiSCs (Figure 4E and 4F; Supplementary information, 
Table S3G). Analysis using Genomic Regions Enrich-
ment of Annotations Tool (GREAT) [38] suggested that 
the ASC-specific HypoMRs (CpG coverage > 40, meth-
ylation difference > 40%) were in the vicinity of genes 
that function in blastocyst formation (e.g., Esrrb and 
Oct4), trophectodermal cell differentiation (e.g., Tead4, 
Tfap2c, Eomes) and dorsal/ventral axis specification 
(e.g., Wnt3, Pax6) (Figure 4G). Promoter methylation 
and gene expression analysis between ASCs and EpiSCs 
suggested an overall weak anti-correlation (Figure 4H). 
However, we found that a small fraction of genes (551) 
were upregulated in ASCs and exhibited promoter de-
methylation. They were enriched for genes involved 
in regulating Meiotic cell cycle (e.g., Mael, Sycp3 and 
Stra8) (Figure 4H; Supplementary information, Table 
S3H and S3I). These germline genes are promoter meth-
ylation-sensitive and are expressed in naive ESCs, where 
their promoters are demethylated. In addition, we found 
that naive pluripotency genes, such as Dppa3, Zfp42 (also 
known as Rex1), Tcl1, Esrrb, Gdf3 and Fbxo15, were 
also promoter demethylated and upregulated in ASCs 
(Figure 4H and 4I; Supplementary information, Figure 
S5D). Thus, ASCs exhibited an overall hypermethylated 
genome and maintained imprints, but showed targeted 
demethylation at loci associated with the preimplantation 
development and naive pluripotency. This is consistent 
with their high contribution in chimeras described above.
Discussion
We describe the derivation of two novel cell types, 
AFSCs and ASCs from mouse blastocysts, which pro-
vide new insights on pluripotent stem cells. In particular, 
the ASCs (advanced pluripotent stem cells) show higher 
DNA methylation levels than naive ESCs (Figure 4A 
and 4B), and with the expression of both pluripotent and 
somatic genes (Figure 3C; Supplementary information, 
Figure 3 RNA-seq analysis of AFSCs and ASCs. (A) Unsupervised hierarchical clustering (UHC) of whole-genome tran-
scriptome from three biological replicates. Note that ASCs were clustered close to ESCs but not EpiSCs. (B) t-distributed 
stochastic neighbor embedding (t-SNE) of whole-genome transcriptome. Arrow represents potential trajectory from naive 
to primed pluripotent stem cells. (C) Heatmap showing scaled expression values of 2 588 differentially expressed genes 
(mean log2(normalized read counts) > 3 in any sample, log2(fold change) > 3, adjusted P-value < 0.05) between the five cell 
types. UHC of five major gene clusters. The top representative GO biological process and InterPro terms for each cluster are 
indicated on the right. (D) Expression heatmap of representative genes for each cluster in C. (E) t-SNE analysis of gene ex-
pression of pluripotent stem cells, and of E2.5-E5.5 embryos [25], based on 1 685 dynamically expressed genes [25]. Arrow 
indicates developmental progression from E2.5 morula to E5.5 postimplantation epiblast. (F) Pair-wise gene expression com-
parison between ASCs and ESCs (2i/LIF). Upregulated (red) and downregulated (blue) genes in ASCs were highlighted (mean 
log2(normalized read counts) > 3 in either samples, log2(fold change) > 2, adjusted P-value < 0.05). Gene ontology analysis (by 
DAVID) showed ASCs upregulated genes that are involved in multicellular organism development and cell differentiation. 
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Figure 4 Methylation analysis of ASCs. (A) Violin plot showing CpG methylation distribution of 2 kilobase (kb) genomic tiles. 
(B) UHC of methylation levels of 2 kb genomic tiles. (C) Heatmap showing CpG methylation of imprint control regions (ICRs) 
in ESCs, ASCs and EpiSCs. (D) Methylation profiles of ESCs hypermethylated regions (HyperMR) in ESCs. Note that Hy-
perMR in ESCs were generally hypermethylated in ASCs and EpiSCs. (E) Venn diagram showing overlap of hypomethylated 
regions (HypoMR) between ASCs and EpiSCs. (F) Methylation profile of ASC-specific HypoMRs in E. (G) GREAT analysis of 
ASC-specific HypoMRs. (H) Scatterplot of differential gene expression and difference in promoter methylation between ASCs 
and EpiSCs. Genes with > 20% promoter methylation and log2 (read counts) > 3 in either samples were shown. Genes up-
regulated in ASCs with promoter demethylation are highlighted in orange. They were enriched for regulating meiotic cell cycle 
and cell pluripotency. Best fit curve (blue line) was generated by the generalized additive models (GAM). (I) UCSC genome 
browser snapshots of CpG methylation level at representative naive pluripotency genes.
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Figure S3E). We also find that genomic imprints are 
more stable in ASCs relative to naive ESCs (Figure 4C). 
On the basis of the transcriptome and DNA methylome 
analysis, ASCs appeared to be at an intermediate state 
between naive ESCs and primed EpiSCs, and appar-
ently represent the cells with the characteristics of the 
early postimplantation epiblast. Remarkably, ASC has 
high developmental potency in chimeras, since a single 
ASC contributes extensively to the developing embryo, 
germline and the extraembryonic mesoderm (Figure 
2J). Indeed it is possible to obtain a live pup consisting 
exclusively of ASCs in “tetraploid rescue experiments”. 
The high potency of individual ASCs may in part be due 
to the shorter cell cycle time (data not shown) and high-
er expression of cMYC in ASCs as compared to that in 
ESCs (Figures 2A and 3F). Accordingly, cMYC might 
promote rapid cell transition through the G1 phase of 
the cell cycle while suppressing cell differentiation by 
activating Dusp2 and Dusp7 phosphatases, which in turn 
represses FGF/ERK signaling [21]. The relevance and 
significance of the cMyc-Dusp2-FGF/ERK pathway in 
ASCs merit further investigation. 
Concerning the extraembryonic tissues, individual 
ASCs do not contribute to the trophectoderm cells when 
introduced into 8-cell stage embryos (Supplementary in-
formation, Figure S4E), unlike some recently described 
pluripotent stem cells [11-14]. This observation is con-
sistent with ASCs being equivalent to early postimplan-
tation epiblast cells, and therefore developmentally they 
represent cells at a later stage when we would not expect 
their contribution to the trophoblast cells, which also ac-
counts for our observation that ASCs did not contribute 
to the extraembryonic endoderm. Nevertheless, single 
ASCs contribute significantly to some extraembryonic 
tissues that originate from the postimplantation epiblast, 
especially the yolk sac mesoderm and placental labyrinth 
in chimeric conceptuses as compared to ESCs; this is 
also a mark of higher potency of ASC [39]. Altogether, 
ASC contribute extensively to the tissues that normally 
originate from postimplantation epiblast cells, which is 
consistent with their overall molecular state and charac-
teristics.  
Another feature of interest concerning ASC involves 
the Hoxa family genes. We found that the lncRNA 
Haunt/Halr1 located ~40 kb upstream of the Hoxa clus-
ter and showed higher expression in ASCs than in ESCs 
(Supplementary information, Figure S3G). The Huant/
Halr1 genomic locus has been shown to be bound by 
pluripotency regulators, including Oct4, Nanog and 
Sox2, with enhancer function-related epigenetic marks, 
such as H3K4me1, DNase I hypersensitivity, H3K4me3 
and H3K36me3 [29, 30]. The Haunt lncRNA and its ge-
nomic locus regulate the Hoxa gene cluster during differ-
entiation of pluripotent cells [31]. Our data suggest that 
high expression of Haunt/Halr1 in ASCs may promote 
downregulation of Hoxa cluster to maintain a stable plu-
ripotent state. 
How precisely the chemically defined ABCL medium 
induces and maintains the hypermethylated state in ASC 
deserves further investigation in the future. The relatively 
hypermethylated state of ASCs with intact genomic im-
prints compared to naive ESCs is likely to provide greater 
stability during self-renewal in vitro, which is consistent 
with the findings of two recent studies on ESCs [40, 41].
The AFSCs we describe in this study are quite similar 
to EpiSCs, which differentiate in the presence of Wnt 
and BMP4 [18, 19]. On the other hand, Activin A and 
LIF support self-renewal of AFSCs and ESC [17], re-
spectively. Thus, during the derivation of ASCs, BMP4 
and CH would likely promote AFSCs toward differentia-
tion, which would be counteracted by Act A and LIF that 
supports self-renewal. Under these signaling conditions, 
a small proportion of surviving cells acquire new pheno-
types and we describe these cells as ASCs. Further de-
tailed analyses, including analysis of epigenetic resetting, 
determining how precisely the ASCs become established 
in culture, need to be explored in the future studies. No-
tably, ESCs can also be readily converted to ASCs, re-
ferred to here as ESC-ASCs, with similar properties.
In conclusion, ASCs are a novel and distinct self-re-
newing type of pluripotent stem cells, which exhibit 
intermediate features between ESCs and EpiSCs. Tran-
scriptionally, ASCs are at a cellular state that beyond the 
epiblast state of the blastocyst. In this respect, ASCs are 
like EpiSCs, albeit some loci remain hypomethylated 
in ASCs, and importantly, female ASCs do not exhibit 
X-inactivation. Thus, ASC represents a unique pluripo-
tent state with distinct transcriptional and epigenetic fea-
tures, which confers greater stability and potency.
 
Materials and Methods
Derivation of AFSC cell lines
Mouse embryos at E3.5 were isolated from 129/sv females 
mated with Oct4-ΔPE-GFP (GOF-GFP), Stella-GFP, Rosa129/Sv 
and Rosa26R-mT/mG transgenic males with a mixed background 
of MF1, 129/sv and C57BL/6J strains [42-44]. The GOF-GFP ex-
pression of the reporter that lacked the proximal enhancer and was 
under the control of the Oct4 promoter and distal enhancer. This 
GFP transgene showed expression in the ICM of blastocysts, PGC 
in vivo and in ESC. Rosa129 is a knockin mouse line with a LacZ 
reporter in the Rosa locus, where LacZ is ubiquitously expressed. 
Standard AF medium consists of N2B27 medium (Life technolo-
gy) supplemented with Activin A (20 ng/ml, R&D Systems) and 
bFGF (12 ng/ml, R&D systems). E3.5 blastocysts were cultured 
in M16 medium (Sigma-Aldrich) for 2 days. Most of them were 
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zone pellucida free. If blastocysts had zona pellucida, they were 
removed by Acidic Tyrode’s Solution (Sigma-Aldrich). They were 
then placed in 24-well fibronectin-coated (16.7 µg/ml, Millipore) 
plate with AF medium. Epiblast cultures grew efficiently and 
formed “flat” epithelial-like colonies after 5-6 days. The resulting 
colonies were further cut into smaller pieces by glass needles after 
7-9 days of culturing, and then the colonies passaged by Accutase 
(Life technology) regularly every 2-3 days. These cells, referred to 
as AFSCs, could be passaged for over 30 passages in AF medium.
Derivation of ASC cell lines
We dissociated GOF-GFP AFSCs using Accutase and placed 
AFSCs (3 × 105 single cells) in fibronectin-coated 24-well plates 
with 1 ml ABCL medium. The ABCL medium was N2B27 me-
dium with Activin A (20 ng/ml, R&D systems), BMP4 (50 ng/
ml, R&D systems), CHIR9902 (3 µM, Miltenyi Biotech) and 
leukemia inhibitory factor (1 000 IU/ml, Millipore). Dependent on 
cell growth, AFSCs were then passaged after 2-4 days. After 6-7 
days of ABCL treatment, we noted cell dying. GOF-GFP-positive 
clones started to appear around day 10-14. When these GFP-pos-
itive colonies grew to around 200 µm in diameter, they were cut 
into smaller pieces using glass needles and then transferred. When 
these colonies had grown for 6-7 days, they were treated with Ac-
cutase, and the resulting cells were cultured to produce GFP-pos-
itive colonies, which were capable of self-renewal for over 30 
passages. We called these cells ASCs.
Teratoma formation
The AFSCs were disaggregated using Accutase, and 1 × 106 
cells were injected under the epithelium of NOD-SCID mice. 
Three to five weeks after transplantation, tumor(s) were collected 
and fixed with 4% paraformaldehyde, and processed for paraffin 
sectioning. Sections were observed following hematoxylin and eo-
sin staining.
Production of chimeras
Approximately, 15-20 cells were injected gently into ICR mice 
blastocoel cavity of blastocysts (E3.5) using a piezo-assisted mi-
cromanipulator attached to an inverted microscope. The injected 
embryos were cultured in KSOM medium (Millipore) to enable 
re-expansion of the blastocoel cavity and then transferred to the 
uteri of pseudopregnant ICR mice at 2.5 days post coitus (dpc). 
In a similar manner to the injection of blastocysts, 8-cell embryos 
(E2.5) were injected with a single cell placed carefully into the 
perivitelline space under the zona pellucida. The embryos were 
cultured overnight in KSOM medium (Millipore) at 37 °C in a 5% 
CO2 atmosphere and transferred to the uteri of pseudopregnant ICR 
mice at 2.5 dpc. The embryos were isolated at embryonic stage 
E6.5-E13.5 with chimeric contribution checked. Full-term chimeras 
were confirmed by the coat color pattern of the pups at birth.
Production of full-term pups in tetraploid host blastocysts
Two-cell stage embryos (E1.5) from ICR mice were collected 
by flushing oviducts; they were subjected to electrofusion to cre-
ate tetraploid (4N) host blastocysts. Typically 15-20 ASCs were 
injected into tetraploid host blastocyts, which were transferred to 
pseudopregnant recipients at 2.5 dpc.
Immunofluorescence
Cells were briefly washed with PBS and fixed in 4% parafor-
maldehyde in PBS for 15 min at room temperature. Cells were 
permeabilized for 30 min with 1% BSA and 0.1% Triton X-100 
in PBS. Antibody staining was carried out in the same buffer at 
4 °C overnight. The slides were subsequently washed three times 
in PBS with 1% BSA, 0.1% Triton X-100 (5 min each wash), then 
incubated with secondary antibody for 1 h at room temperature in 
the dark, washed once for 5 min in 1% BSA, 0.1% Triton X-100 
in PBS and twice for 5 min in PBS. The slides were then mounted 
in Vectashield with DAPI (Vector Laboratories) and imaged using 
a BioRad Radiance 2100 confocal microscope. Primary antibodies 
used were: mouse monoclonal Oct4 (BD Biosciences, 1:200), rat 
monoclonal Nanog (eBioscience, 1:500), goat polyclonal Sox2 
(Santa Cruz, 1:200), rabbit polyclonal H3K27me3 (Upstate, 1:500), 
rat monoclonal E-cadherin (Takara, 1:40), Klf4 (Abcam, 1:300), 
cMyc (Abcam, 1:200), Esrrb (Abcam, 1:200), Prdm14 (Abcam, 
1:200), HNF4a (Santa Cruz, 1:100). All secondary antibodies used 
were Alexa Fluor highly cross-adsorbed (Molecular Probes).
RNA-seq library preparation
The RNA-seq libraries for this paper were constructed by using 
NEBNext Ultra Directional RNA Library Prep Kit from Illumina. 
After isolation of total RNA from bulk amount of mouse stem cells 
using RNeasy Micro Kit (Qiagen), ~500 ng total RNA was used to 
enrich mRNA with polyA tails by using NEBNext Magnetic Oligo 
d(T)25 beads. After RNA fragmentation and random priming, the 
first strand cDNAs and second strand cDNAs were synthesized, 
which was followed by end repair, dA-tailing, adapter ligation and 
PCR enrichment. The RNA-seq libraries were sequenced on HiS-
eq4000 platform.
RNA-seq analysis
Paired-end RNA-seq reads were mapped to the mouse refer-
ence genome (GRCm38/mm10) with TopHat2 (https://ccb.jhu.edu/
software/tophat), and one mismatch was allowed. The alignments 
were guided by Ensembl gene models (Ensembl release 86). Read 
counts for either the full transcript or only the first exon were 
obtained with featureCounts (http://bioinf.wehi.edu.au/feature-
Counts). Transcript or first exon counts were normalized, and the 
statistical significance of differential expression between samples 
was assessed using the R Bioconductor DESeq2 package (https://
bioconductor.org/packages/release/bioc/html/DESeq2.html). Tran-
script and exon counts normalized by DESeq2 size factors were 
subsequently normalized by their length/1 000. RNA-seq data [25] 
from early mouse embryos were obtained from the European Nu-
cleotide Archive (accession number: ERP007120), and identically 
processed.
Paired-end reads were further aligned to the mouse reference 
genome (GRCm38/mm10) with bowtie (options: “-M 1 – v2 – best 
– strata”). RepeatMasker annotations of transposable elements on 
the mouse reference genome were obtained from the UCSC ge-
nome browser table (GRCm38/mm10). Counts for all TE copies 
and Ensembl transcripts were obtained using featureCounts, and 
TE counts were subsequently processed by DESeq2 as described 
above, with the exception that TE counts were normalized by the 
total number of transcript counts instead of DESeq2 size factors.
The top 90% expressed genes (log2(normalized counts)) in 
the whole RNA-seq data set were used for clustering analysis. 
Pearson correlation analysis was performed by the R cor function 
with “1-Pearson correlation coefficient” as a distance metric. UHC 
analysis was performed by the R hclust function with the “ward” 
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method and Euclidean distance metric. t-SNE analysis was per-
formed using the R Rtsne function omitting an initial PCA step. 
PCA analysis was performed with the R prcomp function on cen-
tered and scaled log2(normalized counts) expression values. GSEA 
analysis was performed by the javaGSEA programme developed 
by the Broad Institute.
Real-time PCR
The cDNAs from bulk amount (2 µg) of total RNAs were 
diluted 10 to 40-fold. Then 2 µl of diluted cDNAs was used for 
each 20 µl real-time PCR reaction (1× Syber Green PCR Master 
Mix, 0.2 µM of each primer). All reactions were duplicated. The 
PCR was carried out as follows: first, 95 °C for 10 min to activate 
the Taq polymerase, followed by 40 cycles at 95 °C for 15 s (for 
denaturation) and for 1 min at 60 °C for annealing and extension. 
Finally a dissociation step was run to exclude the possibility of 
non-specific amplification.
LacZ staining
The embryos were isolated and washed twice in PBS. Then 
they were transferred to a cold solution (2% formaldehyde, 0.2% 
glutaraldehyde, 0.02% NP-40, 1 mM MgCl2, 0.01% sodium de-
oxycholate in PBS) and fixed for 2 h at 4 °C on a rocking platform. 
The embryos were washed three times in PBS for 2 min each, and 
stained in lacZ staining solution (0.4 mg/ml Xgal, 4 mM potassium 
ferrocyanide, 4 mM potassium ferricyanide, 1 mM MgCl2, 0.02% 
NP-40 in PBS) at 30 °C for 18-36 h in dark. Details of ingredient 
information are shown below:
Formaldehyde, Sigma-Aldrich; Glutaraldehyde, BioChemika 
(Fluka); NP-40, Roche;
MgCl2, Sigma-Aldrich; Sodium deoxycholate, Sigma-Aldrich; 
Xgal, Melford, MB1001;
Potassium ferrocyanide, Sigma-Aldrich; Potassium ferricya-
nide, Sigma-Aldrich.
Alkaline phosphatase staining
Alkaline phosphatase (AP) staining was carried out using AP 
Staining Kit from Sigma (86R-1KT) according to manufacturer’s 
instructions. Briefly, the cells were fixed by 4% paraformaldehyde 
for 10 min, and then were stained overnight by AP staining solu-
tion at room temperature in the dark.
BS-seq library preparation
Genomic DNA (two biological replicates per condition) was 
extracted by QIAamp DNA Micro Kit (Qiagen). Subsequently, 
100 ng of genomic DNA was subjected to 3.5 h bisulfite treatment 
using the Methylcode Bisulfite Conversion Kit (Invitrogen). To 
monitor the bisulfite conversion efficiency, unmethylated Lambda 
DNA (0.5 ng, Promega) was spiked-in before conversion. Sin-
gle-stranded BS-converted DNA was subjected to the post-bisul-
fite adaptor tagging (PBAT) protocol as described previously [45, 
46]. Libraries were subjected to single-end 100 bp sequencing on 
HiSeq 4000 sequencing system (Illumina). Coverage information 
was summarized in Supplementary information, Table S3.
BS-seq analysis
PBAT reads were quality-trimmed with Trim Galore (http://
www.bioinformatics.babraham.ac.uk/projects/trim_galore), and 
4 nt random primer sequences at the 5′ end and 1 nt at the 3′ end 
of all reads were removed. PBAT reads were then mapped to the 
computationally bisulfite-converted mouse reference genome 
(GRCm38/mm10) by using Bismark [47] (version: 0.16.3; param-
eter settings: “bismark --pbat -N 1 -L 40”). Potential PCR dupli-
cates were removed using the deduplicate bismark command.
Post-alignment analysis was performed by using the MethPipe 
package [37]. First, aligned sequences were converted to MethPipe 
format using the to-mr command. Methylation levels and coverage 
for each symmetric CpG site were calculated by the methcounts 
and symmetric-cpgs commands. Average CpG methylation levels 
of annotated genomic regions, i.e., promoters, exons, repeats, 
imprint control regions, CGIs, enhancers and 2 kb genomic tiles, 
were calculated with the MethPipe roimethstat program. Only 
high-confidence genomic regions with at least 40 CpG observa-
tions from reads in the region were used in further analyses.
About 2 kb tiles were calculated for all chromosomes with a 1 
kb offset. Coordinates of promoters (−1 000 bp and +100 bp from 
the transcription start site (TSS)), exons, introns and intergenic 
regions were retrieved from Ensembl (Mouse Release 86). CGI 
annotations were obtained from the UCSC Table Browser. Imprint 
control region annotations were obtained from Tomizawa et al [48]. 
Tissue-specific enhancer coordinates (± 1 000 bp from peak; mm9 
coordinates were converted to mm10 by the UCSC liftOver tool) 
were retrieved from the Mouse Encode Project [49]. HyperMRs 
and hypomethylated regions were calculated by the hmr command 
from the MethPipe package.
UHC of 2 kb tile methylation was performed using the R hclust 
command with the “ward” method. Correlation matrix was cal-
culated by the R corrplot package. Profile plot was created by the 
R seqplots package. Gene ontology analysis was performed by 
GREAT [50] and DAVID Bioinformatics Resource 6.8 [50].
Data accession
All the sequencing data were deposited in the NCBI, Gene Ex-
pression Omnibus (GEO) under accession number GSE99494.
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